Medical Care
Global Pharmaceutical Development Preclinical CRO Market Research Report 2025
- Mar 11, 25
- ID: 20196
- Pages: 86
- Figures: 90
- Views: 1
The global market for Pharmaceutical Development Preclinical CRO was valued at US$ 13430 million in the year 2024 and is projected to reach a revised size of US$ 22860 million by 2031, growing at a CAGR of 8.0% during the forecast period.
A preclinical CRO (contract research organizations) helps new medical product developers (including devices, drugs, biologics and more) prove those products are safe and effective in live models the FDA deems approximate as closely as possible the human anatomy prior to those devices enter clinical trials (or receiving other approvals like 510Ks) or use for human care. Pharmaceutical companies invest lots of money to research and produce drugs/medicines for patients. Patients and healthcare providers (doctors, nurses, hospitals, nursing homes, clinics, etc.) are all dependent on these companies for the treatment of diseases.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Development Preclinical CRO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Development Preclinical CRO.
The Pharmaceutical Development Preclinical CRO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical Development Preclinical CRO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Development Preclinical CRO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River
Wuxi AppTec
Labcorp
Eurofins Scientific
PPD, Inc.
ICON Plc.
Pharmaron
Inotiv
ChemPartner
JOINN Lab
EVOTEC
Medicilon
Crown Bioscience
Champion Oncology
Segment by Type
Bioanalysis and DMPK Studies
Toxicology Testing
Safety Pharmacology
Others
Segment by Application
Small and Medium Pharmaceutical Company
Large Pharmaceutical Company
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Development Preclinical CRO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A preclinical CRO (contract research organizations) helps new medical product developers (including devices, drugs, biologics and more) prove those products are safe and effective in live models the FDA deems approximate as closely as possible the human anatomy prior to those devices enter clinical trials (or receiving other approvals like 510Ks) or use for human care. Pharmaceutical companies invest lots of money to research and produce drugs/medicines for patients. Patients and healthcare providers (doctors, nurses, hospitals, nursing homes, clinics, etc.) are all dependent on these companies for the treatment of diseases.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Development Preclinical CRO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Development Preclinical CRO.
The Pharmaceutical Development Preclinical CRO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical Development Preclinical CRO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Development Preclinical CRO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River
Wuxi AppTec
Labcorp
Eurofins Scientific
PPD, Inc.
ICON Plc.
Pharmaron
Inotiv
ChemPartner
JOINN Lab
EVOTEC
Medicilon
Crown Bioscience
Champion Oncology
Segment by Type
Bioanalysis and DMPK Studies
Toxicology Testing
Safety Pharmacology
Others
Segment by Application
Small and Medium Pharmaceutical Company
Large Pharmaceutical Company
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Development Preclinical CRO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Development Preclinical CRO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Bioanalysis and DMPK Studies
1.2.3 Toxicology Testing
1.2.4 Safety Pharmacology
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pharmaceutical Development Preclinical CRO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Small and Medium Pharmaceutical Company
1.3.3 Large Pharmaceutical Company
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Development Preclinical CRO Market Perspective (2020-2031)
2.2 Global Pharmaceutical Development Preclinical CRO Growth Trends by Region
2.2.1 Global Pharmaceutical Development Preclinical CRO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pharmaceutical Development Preclinical CRO Historic Market Size by Region (2020-2025)
2.2.3 Pharmaceutical Development Preclinical CRO Forecasted Market Size by Region (2026-2031)
2.3 Pharmaceutical Development Preclinical CRO Market Dynamics
2.3.1 Pharmaceutical Development Preclinical CRO Industry Trends
2.3.2 Pharmaceutical Development Preclinical CRO Market Drivers
2.3.3 Pharmaceutical Development Preclinical CRO Market Challenges
2.3.4 Pharmaceutical Development Preclinical CRO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Development Preclinical CRO Players by Revenue
3.1.1 Global Top Pharmaceutical Development Preclinical CRO Players by Revenue (2020-2025)
3.1.2 Global Pharmaceutical Development Preclinical CRO Revenue Market Share by Players (2020-2025)
3.2 Global Pharmaceutical Development Preclinical CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pharmaceutical Development Preclinical CRO Revenue
3.4 Global Pharmaceutical Development Preclinical CRO Market Concentration Ratio
3.4.1 Global Pharmaceutical Development Preclinical CRO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Development Preclinical CRO Revenue in 2024
3.5 Global Key Players of Pharmaceutical Development Preclinical CRO Head office and Area Served
3.6 Global Key Players of Pharmaceutical Development Preclinical CRO, Product and Application
3.7 Global Key Players of Pharmaceutical Development Preclinical CRO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Development Preclinical CRO Breakdown Data by Type
4.1 Global Pharmaceutical Development Preclinical CRO Historic Market Size by Type (2020-2025)
4.2 Global Pharmaceutical Development Preclinical CRO Forecasted Market Size by Type (2026-2031)
5 Pharmaceutical Development Preclinical CRO Breakdown Data by Application
5.1 Global Pharmaceutical Development Preclinical CRO Historic Market Size by Application (2020-2025)
5.2 Global Pharmaceutical Development Preclinical CRO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pharmaceutical Development Preclinical CRO Market Size (2020-2031)
6.2 North America Pharmaceutical Development Preclinical CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pharmaceutical Development Preclinical CRO Market Size by Country (2020-2025)
6.4 North America Pharmaceutical Development Preclinical CRO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical Development Preclinical CRO Market Size (2020-2031)
7.2 Europe Pharmaceutical Development Preclinical CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pharmaceutical Development Preclinical CRO Market Size by Country (2020-2025)
7.4 Europe Pharmaceutical Development Preclinical CRO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Development Preclinical CRO Market Size (2020-2031)
8.2 Asia-Pacific Pharmaceutical Development Preclinical CRO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pharmaceutical Development Preclinical CRO Market Size by Region (2020-2025)
8.4 Asia-Pacific Pharmaceutical Development Preclinical CRO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical Development Preclinical CRO Market Size (2020-2031)
9.2 Latin America Pharmaceutical Development Preclinical CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pharmaceutical Development Preclinical CRO Market Size by Country (2020-2025)
9.4 Latin America Pharmaceutical Development Preclinical CRO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Development Preclinical CRO Market Size (2020-2031)
10.2 Middle East & Africa Pharmaceutical Development Preclinical CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pharmaceutical Development Preclinical CRO Market Size by Country (2020-2025)
10.4 Middle East & Africa Pharmaceutical Development Preclinical CRO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Details
11.1.2 Charles River Business Overview
11.1.3 Charles River Pharmaceutical Development Preclinical CRO Introduction
11.1.4 Charles River Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025)
11.1.5 Charles River Recent Development
11.2 Wuxi AppTec
11.2.1 Wuxi AppTec Company Details
11.2.2 Wuxi AppTec Business Overview
11.2.3 Wuxi AppTec Pharmaceutical Development Preclinical CRO Introduction
11.2.4 Wuxi AppTec Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025)
11.2.5 Wuxi AppTec Recent Development
11.3 Labcorp
11.3.1 Labcorp Company Details
11.3.2 Labcorp Business Overview
11.3.3 Labcorp Pharmaceutical Development Preclinical CRO Introduction
11.3.4 Labcorp Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025)
11.3.5 Labcorp Recent Development
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Details
11.4.2 Eurofins Scientific Business Overview
11.4.3 Eurofins Scientific Pharmaceutical Development Preclinical CRO Introduction
11.4.4 Eurofins Scientific Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025)
11.4.5 Eurofins Scientific Recent Development
11.5 PPD, Inc.
11.5.1 PPD, Inc. Company Details
11.5.2 PPD, Inc. Business Overview
11.5.3 PPD, Inc. Pharmaceutical Development Preclinical CRO Introduction
11.5.4 PPD, Inc. Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025)
11.5.5 PPD, Inc. Recent Development
11.6 ICON Plc.
11.6.1 ICON Plc. Company Details
11.6.2 ICON Plc. Business Overview
11.6.3 ICON Plc. Pharmaceutical Development Preclinical CRO Introduction
11.6.4 ICON Plc. Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025)
11.6.5 ICON Plc. Recent Development
11.7 Pharmaron
11.7.1 Pharmaron Company Details
11.7.2 Pharmaron Business Overview
11.7.3 Pharmaron Pharmaceutical Development Preclinical CRO Introduction
11.7.4 Pharmaron Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025)
11.7.5 Pharmaron Recent Development
11.8 Inotiv
11.8.1 Inotiv Company Details
11.8.2 Inotiv Business Overview
11.8.3 Inotiv Pharmaceutical Development Preclinical CRO Introduction
11.8.4 Inotiv Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025)
11.8.5 Inotiv Recent Development
11.9 ChemPartner
11.9.1 ChemPartner Company Details
11.9.2 ChemPartner Business Overview
11.9.3 ChemPartner Pharmaceutical Development Preclinical CRO Introduction
11.9.4 ChemPartner Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025)
11.9.5 ChemPartner Recent Development
11.10 JOINN Lab
11.10.1 JOINN Lab Company Details
11.10.2 JOINN Lab Business Overview
11.10.3 JOINN Lab Pharmaceutical Development Preclinical CRO Introduction
11.10.4 JOINN Lab Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025)
11.10.5 JOINN Lab Recent Development
11.11 EVOTEC
11.11.1 EVOTEC Company Details
11.11.2 EVOTEC Business Overview
11.11.3 EVOTEC Pharmaceutical Development Preclinical CRO Introduction
11.11.4 EVOTEC Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025)
11.11.5 EVOTEC Recent Development
11.12 Medicilon
11.12.1 Medicilon Company Details
11.12.2 Medicilon Business Overview
11.12.3 Medicilon Pharmaceutical Development Preclinical CRO Introduction
11.12.4 Medicilon Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025)
11.12.5 Medicilon Recent Development
11.13 Crown Bioscience
11.13.1 Crown Bioscience Company Details
11.13.2 Crown Bioscience Business Overview
11.13.3 Crown Bioscience Pharmaceutical Development Preclinical CRO Introduction
11.13.4 Crown Bioscience Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025)
11.13.5 Crown Bioscience Recent Development
11.14 Champion Oncology
11.14.1 Champion Oncology Company Details
11.14.2 Champion Oncology Business Overview
11.14.3 Champion Oncology Pharmaceutical Development Preclinical CRO Introduction
11.14.4 Champion Oncology Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025)
11.14.5 Champion Oncology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Development Preclinical CRO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Bioanalysis and DMPK Studies
1.2.3 Toxicology Testing
1.2.4 Safety Pharmacology
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pharmaceutical Development Preclinical CRO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Small and Medium Pharmaceutical Company
1.3.3 Large Pharmaceutical Company
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Development Preclinical CRO Market Perspective (2020-2031)
2.2 Global Pharmaceutical Development Preclinical CRO Growth Trends by Region
2.2.1 Global Pharmaceutical Development Preclinical CRO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pharmaceutical Development Preclinical CRO Historic Market Size by Region (2020-2025)
2.2.3 Pharmaceutical Development Preclinical CRO Forecasted Market Size by Region (2026-2031)
2.3 Pharmaceutical Development Preclinical CRO Market Dynamics
2.3.1 Pharmaceutical Development Preclinical CRO Industry Trends
2.3.2 Pharmaceutical Development Preclinical CRO Market Drivers
2.3.3 Pharmaceutical Development Preclinical CRO Market Challenges
2.3.4 Pharmaceutical Development Preclinical CRO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Development Preclinical CRO Players by Revenue
3.1.1 Global Top Pharmaceutical Development Preclinical CRO Players by Revenue (2020-2025)
3.1.2 Global Pharmaceutical Development Preclinical CRO Revenue Market Share by Players (2020-2025)
3.2 Global Pharmaceutical Development Preclinical CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pharmaceutical Development Preclinical CRO Revenue
3.4 Global Pharmaceutical Development Preclinical CRO Market Concentration Ratio
3.4.1 Global Pharmaceutical Development Preclinical CRO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Development Preclinical CRO Revenue in 2024
3.5 Global Key Players of Pharmaceutical Development Preclinical CRO Head office and Area Served
3.6 Global Key Players of Pharmaceutical Development Preclinical CRO, Product and Application
3.7 Global Key Players of Pharmaceutical Development Preclinical CRO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Development Preclinical CRO Breakdown Data by Type
4.1 Global Pharmaceutical Development Preclinical CRO Historic Market Size by Type (2020-2025)
4.2 Global Pharmaceutical Development Preclinical CRO Forecasted Market Size by Type (2026-2031)
5 Pharmaceutical Development Preclinical CRO Breakdown Data by Application
5.1 Global Pharmaceutical Development Preclinical CRO Historic Market Size by Application (2020-2025)
5.2 Global Pharmaceutical Development Preclinical CRO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pharmaceutical Development Preclinical CRO Market Size (2020-2031)
6.2 North America Pharmaceutical Development Preclinical CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pharmaceutical Development Preclinical CRO Market Size by Country (2020-2025)
6.4 North America Pharmaceutical Development Preclinical CRO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical Development Preclinical CRO Market Size (2020-2031)
7.2 Europe Pharmaceutical Development Preclinical CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pharmaceutical Development Preclinical CRO Market Size by Country (2020-2025)
7.4 Europe Pharmaceutical Development Preclinical CRO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Development Preclinical CRO Market Size (2020-2031)
8.2 Asia-Pacific Pharmaceutical Development Preclinical CRO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pharmaceutical Development Preclinical CRO Market Size by Region (2020-2025)
8.4 Asia-Pacific Pharmaceutical Development Preclinical CRO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical Development Preclinical CRO Market Size (2020-2031)
9.2 Latin America Pharmaceutical Development Preclinical CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pharmaceutical Development Preclinical CRO Market Size by Country (2020-2025)
9.4 Latin America Pharmaceutical Development Preclinical CRO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Development Preclinical CRO Market Size (2020-2031)
10.2 Middle East & Africa Pharmaceutical Development Preclinical CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pharmaceutical Development Preclinical CRO Market Size by Country (2020-2025)
10.4 Middle East & Africa Pharmaceutical Development Preclinical CRO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Details
11.1.2 Charles River Business Overview
11.1.3 Charles River Pharmaceutical Development Preclinical CRO Introduction
11.1.4 Charles River Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025)
11.1.5 Charles River Recent Development
11.2 Wuxi AppTec
11.2.1 Wuxi AppTec Company Details
11.2.2 Wuxi AppTec Business Overview
11.2.3 Wuxi AppTec Pharmaceutical Development Preclinical CRO Introduction
11.2.4 Wuxi AppTec Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025)
11.2.5 Wuxi AppTec Recent Development
11.3 Labcorp
11.3.1 Labcorp Company Details
11.3.2 Labcorp Business Overview
11.3.3 Labcorp Pharmaceutical Development Preclinical CRO Introduction
11.3.4 Labcorp Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025)
11.3.5 Labcorp Recent Development
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Details
11.4.2 Eurofins Scientific Business Overview
11.4.3 Eurofins Scientific Pharmaceutical Development Preclinical CRO Introduction
11.4.4 Eurofins Scientific Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025)
11.4.5 Eurofins Scientific Recent Development
11.5 PPD, Inc.
11.5.1 PPD, Inc. Company Details
11.5.2 PPD, Inc. Business Overview
11.5.3 PPD, Inc. Pharmaceutical Development Preclinical CRO Introduction
11.5.4 PPD, Inc. Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025)
11.5.5 PPD, Inc. Recent Development
11.6 ICON Plc.
11.6.1 ICON Plc. Company Details
11.6.2 ICON Plc. Business Overview
11.6.3 ICON Plc. Pharmaceutical Development Preclinical CRO Introduction
11.6.4 ICON Plc. Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025)
11.6.5 ICON Plc. Recent Development
11.7 Pharmaron
11.7.1 Pharmaron Company Details
11.7.2 Pharmaron Business Overview
11.7.3 Pharmaron Pharmaceutical Development Preclinical CRO Introduction
11.7.4 Pharmaron Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025)
11.7.5 Pharmaron Recent Development
11.8 Inotiv
11.8.1 Inotiv Company Details
11.8.2 Inotiv Business Overview
11.8.3 Inotiv Pharmaceutical Development Preclinical CRO Introduction
11.8.4 Inotiv Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025)
11.8.5 Inotiv Recent Development
11.9 ChemPartner
11.9.1 ChemPartner Company Details
11.9.2 ChemPartner Business Overview
11.9.3 ChemPartner Pharmaceutical Development Preclinical CRO Introduction
11.9.4 ChemPartner Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025)
11.9.5 ChemPartner Recent Development
11.10 JOINN Lab
11.10.1 JOINN Lab Company Details
11.10.2 JOINN Lab Business Overview
11.10.3 JOINN Lab Pharmaceutical Development Preclinical CRO Introduction
11.10.4 JOINN Lab Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025)
11.10.5 JOINN Lab Recent Development
11.11 EVOTEC
11.11.1 EVOTEC Company Details
11.11.2 EVOTEC Business Overview
11.11.3 EVOTEC Pharmaceutical Development Preclinical CRO Introduction
11.11.4 EVOTEC Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025)
11.11.5 EVOTEC Recent Development
11.12 Medicilon
11.12.1 Medicilon Company Details
11.12.2 Medicilon Business Overview
11.12.3 Medicilon Pharmaceutical Development Preclinical CRO Introduction
11.12.4 Medicilon Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025)
11.12.5 Medicilon Recent Development
11.13 Crown Bioscience
11.13.1 Crown Bioscience Company Details
11.13.2 Crown Bioscience Business Overview
11.13.3 Crown Bioscience Pharmaceutical Development Preclinical CRO Introduction
11.13.4 Crown Bioscience Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025)
11.13.5 Crown Bioscience Recent Development
11.14 Champion Oncology
11.14.1 Champion Oncology Company Details
11.14.2 Champion Oncology Business Overview
11.14.3 Champion Oncology Pharmaceutical Development Preclinical CRO Introduction
11.14.4 Champion Oncology Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025)
11.14.5 Champion Oncology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Pharmaceutical Development Preclinical CRO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Bioanalysis and DMPK Studies
Table 3. Key Players of Toxicology Testing
Table 4. Key Players of Safety Pharmacology
Table 5. Key Players of Others
Table 6. Global Pharmaceutical Development Preclinical CRO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Pharmaceutical Development Preclinical CRO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Pharmaceutical Development Preclinical CRO Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Pharmaceutical Development Preclinical CRO Market Share by Region (2020-2025)
Table 10. Global Pharmaceutical Development Preclinical CRO Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Pharmaceutical Development Preclinical CRO Market Share by Region (2026-2031)
Table 12. Pharmaceutical Development Preclinical CRO Market Trends
Table 13. Pharmaceutical Development Preclinical CRO Market Drivers
Table 14. Pharmaceutical Development Preclinical CRO Market Challenges
Table 15. Pharmaceutical Development Preclinical CRO Market Restraints
Table 16. Global Pharmaceutical Development Preclinical CRO Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Pharmaceutical Development Preclinical CRO Market Share by Players (2020-2025)
Table 18. Global Top Pharmaceutical Development Preclinical CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Development Preclinical CRO as of 2024)
Table 19. Ranking of Global Top Pharmaceutical Development Preclinical CRO Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Pharmaceutical Development Preclinical CRO Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Pharmaceutical Development Preclinical CRO, Headquarters and Area Served
Table 22. Global Key Players of Pharmaceutical Development Preclinical CRO, Product and Application
Table 23. Global Key Players of Pharmaceutical Development Preclinical CRO, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pharmaceutical Development Preclinical CRO Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Pharmaceutical Development Preclinical CRO Revenue Market Share by Type (2020-2025)
Table 27. Global Pharmaceutical Development Preclinical CRO Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Pharmaceutical Development Preclinical CRO Revenue Market Share by Type (2026-2031)
Table 29. Global Pharmaceutical Development Preclinical CRO Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Pharmaceutical Development Preclinical CRO Revenue Market Share by Application (2020-2025)
Table 31. Global Pharmaceutical Development Preclinical CRO Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Pharmaceutical Development Preclinical CRO Revenue Market Share by Application (2026-2031)
Table 33. North America Pharmaceutical Development Preclinical CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Pharmaceutical Development Preclinical CRO Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Pharmaceutical Development Preclinical CRO Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Pharmaceutical Development Preclinical CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Pharmaceutical Development Preclinical CRO Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Pharmaceutical Development Preclinical CRO Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Pharmaceutical Development Preclinical CRO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Pharmaceutical Development Preclinical CRO Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Pharmaceutical Development Preclinical CRO Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Pharmaceutical Development Preclinical CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Pharmaceutical Development Preclinical CRO Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Pharmaceutical Development Preclinical CRO Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Pharmaceutical Development Preclinical CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Pharmaceutical Development Preclinical CRO Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Pharmaceutical Development Preclinical CRO Market Size by Country (2026-2031) & (US$ Million)
Table 48. Charles River Company Details
Table 49. Charles River Business Overview
Table 50. Charles River Pharmaceutical Development Preclinical CRO Product
Table 51. Charles River Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025) & (US$ Million)
Table 52. Charles River Recent Development
Table 53. Wuxi AppTec Company Details
Table 54. Wuxi AppTec Business Overview
Table 55. Wuxi AppTec Pharmaceutical Development Preclinical CRO Product
Table 56. Wuxi AppTec Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025) & (US$ Million)
Table 57. Wuxi AppTec Recent Development
Table 58. Labcorp Company Details
Table 59. Labcorp Business Overview
Table 60. Labcorp Pharmaceutical Development Preclinical CRO Product
Table 61. Labcorp Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025) & (US$ Million)
Table 62. Labcorp Recent Development
Table 63. Eurofins Scientific Company Details
Table 64. Eurofins Scientific Business Overview
Table 65. Eurofins Scientific Pharmaceutical Development Preclinical CRO Product
Table 66. Eurofins Scientific Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025) & (US$ Million)
Table 67. Eurofins Scientific Recent Development
Table 68. PPD, Inc. Company Details
Table 69. PPD, Inc. Business Overview
Table 70. PPD, Inc. Pharmaceutical Development Preclinical CRO Product
Table 71. PPD, Inc. Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025) & (US$ Million)
Table 72. PPD, Inc. Recent Development
Table 73. ICON Plc. Company Details
Table 74. ICON Plc. Business Overview
Table 75. ICON Plc. Pharmaceutical Development Preclinical CRO Product
Table 76. ICON Plc. Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025) & (US$ Million)
Table 77. ICON Plc. Recent Development
Table 78. Pharmaron Company Details
Table 79. Pharmaron Business Overview
Table 80. Pharmaron Pharmaceutical Development Preclinical CRO Product
Table 81. Pharmaron Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025) & (US$ Million)
Table 82. Pharmaron Recent Development
Table 83. Inotiv Company Details
Table 84. Inotiv Business Overview
Table 85. Inotiv Pharmaceutical Development Preclinical CRO Product
Table 86. Inotiv Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025) & (US$ Million)
Table 87. Inotiv Recent Development
Table 88. ChemPartner Company Details
Table 89. ChemPartner Business Overview
Table 90. ChemPartner Pharmaceutical Development Preclinical CRO Product
Table 91. ChemPartner Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025) & (US$ Million)
Table 92. ChemPartner Recent Development
Table 93. JOINN Lab Company Details
Table 94. JOINN Lab Business Overview
Table 95. JOINN Lab Pharmaceutical Development Preclinical CRO Product
Table 96. JOINN Lab Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025) & (US$ Million)
Table 97. JOINN Lab Recent Development
Table 98. EVOTEC Company Details
Table 99. EVOTEC Business Overview
Table 100. EVOTEC Pharmaceutical Development Preclinical CRO Product
Table 101. EVOTEC Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025) & (US$ Million)
Table 102. EVOTEC Recent Development
Table 103. Medicilon Company Details
Table 104. Medicilon Business Overview
Table 105. Medicilon Pharmaceutical Development Preclinical CRO Product
Table 106. Medicilon Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025) & (US$ Million)
Table 107. Medicilon Recent Development
Table 108. Crown Bioscience Company Details
Table 109. Crown Bioscience Business Overview
Table 110. Crown Bioscience Pharmaceutical Development Preclinical CRO Product
Table 111. Crown Bioscience Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025) & (US$ Million)
Table 112. Crown Bioscience Recent Development
Table 113. Champion Oncology Company Details
Table 114. Champion Oncology Business Overview
Table 115. Champion Oncology Pharmaceutical Development Preclinical CRO Product
Table 116. Champion Oncology Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025) & (US$ Million)
Table 117. Champion Oncology Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Pharmaceutical Development Preclinical CRO Picture
Figure 2. Global Pharmaceutical Development Preclinical CRO Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pharmaceutical Development Preclinical CRO Market Share by Type: 2024 VS 2031
Figure 4. Bioanalysis and DMPK Studies Features
Figure 5. Toxicology Testing Features
Figure 6. Safety Pharmacology Features
Figure 7. Others Features
Figure 8. Global Pharmaceutical Development Preclinical CRO Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Pharmaceutical Development Preclinical CRO Market Share by Application: 2024 VS 2031
Figure 10. Small and Medium Pharmaceutical Company Case Studies
Figure 11. Large Pharmaceutical Company Case Studies
Figure 12. Pharmaceutical Development Preclinical CRO Report Years Considered
Figure 13. Global Pharmaceutical Development Preclinical CRO Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Pharmaceutical Development Preclinical CRO Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Pharmaceutical Development Preclinical CRO Market Share by Region: 2024 VS 2031
Figure 16. Global Pharmaceutical Development Preclinical CRO Market Share by Players in 2024
Figure 17. Global Top Pharmaceutical Development Preclinical CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Development Preclinical CRO as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Pharmaceutical Development Preclinical CRO Revenue in 2024
Figure 19. North America Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Pharmaceutical Development Preclinical CRO Market Share by Country (2020-2031)
Figure 21. United States Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Pharmaceutical Development Preclinical CRO Market Share by Country (2020-2031)
Figure 25. Germany Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Pharmaceutical Development Preclinical CRO Market Share by Region (2020-2031)
Figure 33. China Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Pharmaceutical Development Preclinical CRO Market Share by Country (2020-2031)
Figure 41. Mexico Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Pharmaceutical Development Preclinical CRO Market Share by Country (2020-2031)
Figure 45. Turkey Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Charles River Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2020-2025)
Figure 49. Wuxi AppTec Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2020-2025)
Figure 50. Labcorp Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2020-2025)
Figure 51. Eurofins Scientific Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2020-2025)
Figure 52. PPD, Inc. Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2020-2025)
Figure 53. ICON Plc. Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2020-2025)
Figure 54. Pharmaron Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2020-2025)
Figure 55. Inotiv Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2020-2025)
Figure 56. ChemPartner Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2020-2025)
Figure 57. JOINN Lab Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2020-2025)
Figure 58. EVOTEC Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2020-2025)
Figure 59. Medicilon Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2020-2025)
Figure 60. Crown Bioscience Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2020-2025)
Figure 61. Champion Oncology Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Pharmaceutical Development Preclinical CRO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Bioanalysis and DMPK Studies
Table 3. Key Players of Toxicology Testing
Table 4. Key Players of Safety Pharmacology
Table 5. Key Players of Others
Table 6. Global Pharmaceutical Development Preclinical CRO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Pharmaceutical Development Preclinical CRO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Pharmaceutical Development Preclinical CRO Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Pharmaceutical Development Preclinical CRO Market Share by Region (2020-2025)
Table 10. Global Pharmaceutical Development Preclinical CRO Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Pharmaceutical Development Preclinical CRO Market Share by Region (2026-2031)
Table 12. Pharmaceutical Development Preclinical CRO Market Trends
Table 13. Pharmaceutical Development Preclinical CRO Market Drivers
Table 14. Pharmaceutical Development Preclinical CRO Market Challenges
Table 15. Pharmaceutical Development Preclinical CRO Market Restraints
Table 16. Global Pharmaceutical Development Preclinical CRO Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Pharmaceutical Development Preclinical CRO Market Share by Players (2020-2025)
Table 18. Global Top Pharmaceutical Development Preclinical CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Development Preclinical CRO as of 2024)
Table 19. Ranking of Global Top Pharmaceutical Development Preclinical CRO Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Pharmaceutical Development Preclinical CRO Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Pharmaceutical Development Preclinical CRO, Headquarters and Area Served
Table 22. Global Key Players of Pharmaceutical Development Preclinical CRO, Product and Application
Table 23. Global Key Players of Pharmaceutical Development Preclinical CRO, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pharmaceutical Development Preclinical CRO Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Pharmaceutical Development Preclinical CRO Revenue Market Share by Type (2020-2025)
Table 27. Global Pharmaceutical Development Preclinical CRO Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Pharmaceutical Development Preclinical CRO Revenue Market Share by Type (2026-2031)
Table 29. Global Pharmaceutical Development Preclinical CRO Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Pharmaceutical Development Preclinical CRO Revenue Market Share by Application (2020-2025)
Table 31. Global Pharmaceutical Development Preclinical CRO Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Pharmaceutical Development Preclinical CRO Revenue Market Share by Application (2026-2031)
Table 33. North America Pharmaceutical Development Preclinical CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Pharmaceutical Development Preclinical CRO Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Pharmaceutical Development Preclinical CRO Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Pharmaceutical Development Preclinical CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Pharmaceutical Development Preclinical CRO Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Pharmaceutical Development Preclinical CRO Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Pharmaceutical Development Preclinical CRO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Pharmaceutical Development Preclinical CRO Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Pharmaceutical Development Preclinical CRO Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Pharmaceutical Development Preclinical CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Pharmaceutical Development Preclinical CRO Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Pharmaceutical Development Preclinical CRO Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Pharmaceutical Development Preclinical CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Pharmaceutical Development Preclinical CRO Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Pharmaceutical Development Preclinical CRO Market Size by Country (2026-2031) & (US$ Million)
Table 48. Charles River Company Details
Table 49. Charles River Business Overview
Table 50. Charles River Pharmaceutical Development Preclinical CRO Product
Table 51. Charles River Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025) & (US$ Million)
Table 52. Charles River Recent Development
Table 53. Wuxi AppTec Company Details
Table 54. Wuxi AppTec Business Overview
Table 55. Wuxi AppTec Pharmaceutical Development Preclinical CRO Product
Table 56. Wuxi AppTec Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025) & (US$ Million)
Table 57. Wuxi AppTec Recent Development
Table 58. Labcorp Company Details
Table 59. Labcorp Business Overview
Table 60. Labcorp Pharmaceutical Development Preclinical CRO Product
Table 61. Labcorp Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025) & (US$ Million)
Table 62. Labcorp Recent Development
Table 63. Eurofins Scientific Company Details
Table 64. Eurofins Scientific Business Overview
Table 65. Eurofins Scientific Pharmaceutical Development Preclinical CRO Product
Table 66. Eurofins Scientific Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025) & (US$ Million)
Table 67. Eurofins Scientific Recent Development
Table 68. PPD, Inc. Company Details
Table 69. PPD, Inc. Business Overview
Table 70. PPD, Inc. Pharmaceutical Development Preclinical CRO Product
Table 71. PPD, Inc. Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025) & (US$ Million)
Table 72. PPD, Inc. Recent Development
Table 73. ICON Plc. Company Details
Table 74. ICON Plc. Business Overview
Table 75. ICON Plc. Pharmaceutical Development Preclinical CRO Product
Table 76. ICON Plc. Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025) & (US$ Million)
Table 77. ICON Plc. Recent Development
Table 78. Pharmaron Company Details
Table 79. Pharmaron Business Overview
Table 80. Pharmaron Pharmaceutical Development Preclinical CRO Product
Table 81. Pharmaron Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025) & (US$ Million)
Table 82. Pharmaron Recent Development
Table 83. Inotiv Company Details
Table 84. Inotiv Business Overview
Table 85. Inotiv Pharmaceutical Development Preclinical CRO Product
Table 86. Inotiv Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025) & (US$ Million)
Table 87. Inotiv Recent Development
Table 88. ChemPartner Company Details
Table 89. ChemPartner Business Overview
Table 90. ChemPartner Pharmaceutical Development Preclinical CRO Product
Table 91. ChemPartner Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025) & (US$ Million)
Table 92. ChemPartner Recent Development
Table 93. JOINN Lab Company Details
Table 94. JOINN Lab Business Overview
Table 95. JOINN Lab Pharmaceutical Development Preclinical CRO Product
Table 96. JOINN Lab Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025) & (US$ Million)
Table 97. JOINN Lab Recent Development
Table 98. EVOTEC Company Details
Table 99. EVOTEC Business Overview
Table 100. EVOTEC Pharmaceutical Development Preclinical CRO Product
Table 101. EVOTEC Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025) & (US$ Million)
Table 102. EVOTEC Recent Development
Table 103. Medicilon Company Details
Table 104. Medicilon Business Overview
Table 105. Medicilon Pharmaceutical Development Preclinical CRO Product
Table 106. Medicilon Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025) & (US$ Million)
Table 107. Medicilon Recent Development
Table 108. Crown Bioscience Company Details
Table 109. Crown Bioscience Business Overview
Table 110. Crown Bioscience Pharmaceutical Development Preclinical CRO Product
Table 111. Crown Bioscience Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025) & (US$ Million)
Table 112. Crown Bioscience Recent Development
Table 113. Champion Oncology Company Details
Table 114. Champion Oncology Business Overview
Table 115. Champion Oncology Pharmaceutical Development Preclinical CRO Product
Table 116. Champion Oncology Revenue in Pharmaceutical Development Preclinical CRO Business (2020-2025) & (US$ Million)
Table 117. Champion Oncology Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Pharmaceutical Development Preclinical CRO Picture
Figure 2. Global Pharmaceutical Development Preclinical CRO Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pharmaceutical Development Preclinical CRO Market Share by Type: 2024 VS 2031
Figure 4. Bioanalysis and DMPK Studies Features
Figure 5. Toxicology Testing Features
Figure 6. Safety Pharmacology Features
Figure 7. Others Features
Figure 8. Global Pharmaceutical Development Preclinical CRO Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Pharmaceutical Development Preclinical CRO Market Share by Application: 2024 VS 2031
Figure 10. Small and Medium Pharmaceutical Company Case Studies
Figure 11. Large Pharmaceutical Company Case Studies
Figure 12. Pharmaceutical Development Preclinical CRO Report Years Considered
Figure 13. Global Pharmaceutical Development Preclinical CRO Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Pharmaceutical Development Preclinical CRO Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Pharmaceutical Development Preclinical CRO Market Share by Region: 2024 VS 2031
Figure 16. Global Pharmaceutical Development Preclinical CRO Market Share by Players in 2024
Figure 17. Global Top Pharmaceutical Development Preclinical CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Development Preclinical CRO as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Pharmaceutical Development Preclinical CRO Revenue in 2024
Figure 19. North America Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Pharmaceutical Development Preclinical CRO Market Share by Country (2020-2031)
Figure 21. United States Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Pharmaceutical Development Preclinical CRO Market Share by Country (2020-2031)
Figure 25. Germany Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Pharmaceutical Development Preclinical CRO Market Share by Region (2020-2031)
Figure 33. China Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Pharmaceutical Development Preclinical CRO Market Share by Country (2020-2031)
Figure 41. Mexico Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Pharmaceutical Development Preclinical CRO Market Share by Country (2020-2031)
Figure 45. Turkey Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Charles River Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2020-2025)
Figure 49. Wuxi AppTec Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2020-2025)
Figure 50. Labcorp Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2020-2025)
Figure 51. Eurofins Scientific Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2020-2025)
Figure 52. PPD, Inc. Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2020-2025)
Figure 53. ICON Plc. Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2020-2025)
Figure 54. Pharmaron Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2020-2025)
Figure 55. Inotiv Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2020-2025)
Figure 56. ChemPartner Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2020-2025)
Figure 57. JOINN Lab Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2020-2025)
Figure 58. EVOTEC Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2020-2025)
Figure 59. Medicilon Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2020-2025)
Figure 60. Crown Bioscience Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2020-2025)
Figure 61. Champion Oncology Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Circuit Simulator Market Research Report 2025
Mar 11, 25
Global Schematic Editor Market Research Report 2025
Mar 11, 25
Global Milk Green Tea Market Research Report 2025
Mar 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232